ACCD News and Press, Accolade Inc.

2024-04-30 02:15:02 ET Wells Fargo analyst issues EQUAL-WEIGHT recommendation for ACCD on April 30, 2024 12:31AM ET. The previous analyst recommendation was Equal-Weight. ACCD was trading at $8.19 at issue of the analyst recommendation. The overall analyst consensus : BU...

2024-04-30 02:00:03 ET Stan Berenshteyn from Wells Fargo issued a price target of $10.00 for ACCD on 2024-04-30 00:31:00. The adjusted price target was set to $10.00. At the time of the announcement, ACCD was trading at $8.19. The overall price target consensus is at $19...

2024-04-26 17:00:42 ET Gainers: Heartland Financial USA ( HTLF ) +9% . Accolade ( ACCD ) +6% . Editas Medicine ( EDIT ) +4% . Nextracker ( NXT ) +3% . Clean Energy Fuels ( CLNE ) +2% . Losers: Vitru  ( VTRU ) -...

2024-04-25 23:29:07 ET Accolade, Inc. (ACCD) Q4 2024 Earnings Conference Call April 25, 2024 16:30 ET Company Participants Todd Friedman - Senior Vice President of Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer ...

2024-04-25 17:31:10 ET Gainers: Alphabet  ( GOOGL ) +15% . Alphabet  ( GOOG ) +15% . Exponent ( EXPO ) +13% . Columbia Sportswear ( COLM ) +8% . SPS Commerce ( SPSC ) +6% . Losers: Intel Corporation ( INTC )...

2024-04-25 16:15:53 ET More on Accolade Accolade: Staying Bullish On Favorable Developments Progyny slips amid concerns over Alabama fertility ruling Seeking Alpha’s Quant Rating on Accolade Historical earnings data for Accolade Financial infor...

SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare services business at scale with consistently strong growth rates. Whether se...

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

2024-04-24 17:20:18 ET More on Accolade Accolade: Staying Bullish On Favorable Developments Progyny slips amid concerns over Alabama fertility ruling Seeking Alpha’s Quant Rating on Accolade Historical earnings data for Accolade Financial infor...

2024-04-09 11:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...